Newsroom | 97227 results

BURLINGTON, Mass.--(BUSINESS WIRE)--PharmaEssentia Corporation (TWSE: 6446), a global biopharmaceutical company headquartered in Taiwan with deep expertise in the development of novel biologics for hematology and oncology, and its U.S. subsidiary PharmaEssentia USA Corporation today announced that the global corporate Board of Directors has approved an investment of approximately US$46 million to establish a new, wholly owned manufacturing subsidiary in Puerto Rico. The planned investment suppo...

MARLBOROUGH, Mass.--(BUSINESS WIRE)--SCIEX announces Echo® MS+ system integration with ZenoTOF 8600 system, delivering enhanced sensitivity for high-throughput screening....

PORTAGE, Mich.--(BUSINESS WIRE)--Traumasoft, a leading provider of integrated EMS management solutions, is pleased to announce the acquisition of Huly, a specialized AI platform purpose-built to improve workflow efficiency, compliance, and staff experience across EMS operations. The acquisition reflects Traumasoft’s belief that AI is essential infrastructure for the EMS industry and must remain interoperable across the EMS ecosystem. As part of the transaction, Huly will retain its independent...

LONDON & BOSTON--(BUSINESS WIRE)--Convatec, a global medical products and technologies company focused on solutions for the management of chronic conditions, has been awarded two group purchasing agreements in the Enterostomal Therapy Products category with Premier, Inc., effective April 1, 2026: National Agreement: The new agreement allows Premier members, at their discretion, to take advantage of special pricing and terms pre-negotiated by Premier for enterostomal therapy products. AscenDrive...

WESTMINSTER, Colo.--(BUSINESS WIRE)--TriSalus Life Sciences, Inc. (Nasdaq: TLSI) (“TriSalus” or the “Company”), an oncology-focused medical technology company advancing novel drug delivery technologies alongside standard-of-care therapies to improve outcomes for patients with solid tumors, today announced changes to its Board of Directors. TriSalus announced that Dr. Arjun “JJ” Desai, a member of the Board since August of 2023, has elected to resign from the Board. The Company and the Board exp...

BENGALURU, India & SAN CARLOS, Calif.--(BUSINESS WIRE)--Pandorum Technologies Raises US$18 Million in Series B to Advance Global Access to Programmable Tissue Regenerative Therapies....

SEOUL, South Korea--(BUSINESS WIRE)--Biotech Galux secures $29M Series B to accelerate its AI-driven de novo antibody design platform....

PISCATAWAY, N.J.--(BUSINESS WIRE)--Kashiv BioSciences, LLC (“Kashiv”) a vertically integrated biopharmaceutical company, today announced that it has entered into an exclusive licensing and supply agreement with Intas Pharmaceuticals Ltd (“Intas”), a leading multinational pharmaceutical company. The complex peptide product will be commercialized by Intas in India and its subsidiary, Accord Healthcare Ltd (“Accord”), in Europe and the UK. The agreement covers pan-European, UK, and India markets....

MENLO PARK, Calif.--(BUSINESS WIRE)--One Mind™, a leading mental health nonprofit based in Napa Valley, CA, today announced the selected startups of the 2026 One Mind Accelerator, a 10-week immersive program designed to offer critical domain expertise and hands-on support for business development, company building, fundraising, and founder development. This is the fourth cohort of the One Mind Accelerator since its launch in 2023. The 14 companies in the 2026 cohort were selected from a record-...

LOS ANGELES--(BUSINESS WIRE)--Niagen Bioscience, Inc. (NASDAQ: NAGE), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today announces it is the headlining sponsor of the inaugural NAD for Health: Opportunities & Challenges scientific meeting hosted by the University of Copenhagen, taking place March 23–25, 2026 at the Royal Danish Academy of Sciences and Letters in central Copenhagen. Space is limited and registration is require...